Powered by
Morning Alert: Immunovaccine tumbles 6.2% 02 March 2017 11:44 EST
Mar 2, 2017 - News Bites Canadian Markets

CANADIAN DAILY STOCK REPORT

Immunovaccine Inc. (TSX:IMV), Canada's 11th largest Biotechnology company by market cap, has dropped 5.0c (3.8%) from its last trading session of March 01 to close at CAD1.25. Compared with the S&P/TSX 60 Index which fell 1.3 points (0.1%) in the day, the relative price change was -3.7%. The fall was exacerbated by robust volume of 1.5 times the average daily volume of 121,149 shares.

DIRECTORS BUYING

Pierre Labbe insider bought 15,000 shares worth

Sign up for unrestricted access to 200+ subscription services.
Already have an account? Click here to login.

RelSci News & Alerts gets you:

  • 5 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
  • Competitive business intelligence through daily data updates
  • Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox